Liver Diseases in Latin America: Current Status, Unmet Needs, and Opportunities for Improvement
Authors:
- 16 June 2022
- journal article
- review article
- Published by Springer Nature in Current Treatment Options in Gastroenterology
- Vol. 20 (3) , 261-278
Abstract
Purpose of review To assess the current challenges regarding liver diseases, including the burden of disease, access to care, screening, and treatment needs in Latin America. Recent findings Latin America is a region with a rich multicultural heritage and important socioeconomic differences. The burden of liver diseases is high and mainly determined by a high level of alcohol intake and the surge of risk factors associated with NAFLD (i.e., sedentary lifestyles, broader access to highly processed foods, obesity, and type 2 diabetes mellitus). Hepatotropic viruses also play a role in the development of chronic liver diseases, although their comparative frequency has been decreasing over the last decades. There are important disparities in access to screening and treatment for liver diseases in Latin America, which are reflected in low access to critical treatments such as direct-acting antiviral agents and drugs to treat hepatocellular carcinoma. Also, important barriers to liver transplantation are present in multiple countries, including a low deceased donors’ rate and a lack of availability in several countries (especially in Central America). Our region also has disadvantages in research and education in liver diseases, which limits regional academic development and improvement in quality of care of liver diseases. Summary In order to tackle an increasing health burden due to liver diseases, Latin America urgently needs tailored interventions aiming to control the main risk factors for these disorders through the establishment of effective public health policies. Also, development of liver transplantation programs and improvement of medical education and research capabilities as well as extensive collaboration between all stakeholders are keys to address the liver disease agenda in the region.Keywords
Funding Information
- Fondo Nacional de Desarrollo Científico y Tecnológico (1200227, 1191145)
This publication has 96 references indexed in Scilit:
- Trends and projections of hepatitis C virus epidemiology in Latin AmericaLiver International, 2011
- Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver diseaseHepatology, 2011
- The prevalence of metabolic syndrome in Latin America: a systematic reviewPublic Health Nutrition, 2011
- Epidemic of metabolic syndrome in Latin AmericaCurrent Opinion in Endocrinology, Diabetes and Obesity, 2011
- Evolving epidemiology of hepatitis C virusClinical Microbiology and Infection, 2011
- Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasiansHepatology, 2010
- Model for end-stage liver disease-based allocation system for liver transplantation in Argentina: does it work outside the United States?HPB, 2010
- Epidemiology of Hepatitis B and C Viruses: A Global OverviewClinics in Liver Disease, 2010
- Prevalence of the Metabolic Syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional studyCardiovascular Diabetology, 2009
- Hepatite DRevista da Sociedade Brasileira de Medicina Tropical, 2002